{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-002316","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.332479+00:00","generated_at":"2026-05-15T05:46:23.192770+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cosmos Health reports record FY2025 revenue $65.3M, up 20%; gross profit +83%, adjusted EPS improves 82%","bullets":["Revenue $65.3M (+20% YoY); gross profit $7.9M (+83%); gross margin 12.1% (+418 bps).","Adjusted EPS improved to ($0.12) from ($0.65) (+82%); adjusted EBITDA loss narrowed to $3.36M.","Cash and equivalents $3.5M, up 10x from $0.3M; total assets $65.5M (+21%).","CEO Greg Siokas increased ownership by 3.3M shares; secured $300M digital asset financing facility.","Contract manufacturing deals for 12M+ units; Sky Premium Life 60 new SKUs; U.S. expansion with NOOR Collagen."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-002316","json":"https://secwatch.observer/filing/0001477932-26-002316.json","markdown":"https://secwatch.observer/filing/0001477932-26-002316.md","text":"https://secwatch.observer/filing/0001477932-26-002316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/0001477932-26-002316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:46:23.192770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39204e3df6f4d7031f7ae3d2d6fde139f04a3fd6","claim":"Cosmos Health Inc. reported the full year ended December 31, 2025 results: revenue $65.27 million, net income ($19.14 million), EPS ($0.63).","evidence_excerpt":"through Decahedron in the United Kingdom, and the global expansion of proprietary brands, including Sky Premium Life and C-Scrub. Key Metric FY 2025 FY 2024 Change (in $) Revenue 65,271,815 54,426,402 +20 % Gross Profit 7,895,575 4,311,323 +83 % Gross Margin 12.10 % 7.92 % +418 basis points Adjusted EBITDA (3,361,385 ) (3,438,975 ) 2% improvement Adjusted Net Income","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/0001477932-26-002316-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2025"},{"label":"Revenue","value":"$65.27 million"},{"label":"Net income","value":"($19.14 million)"},{"label":"EPS","value":"($0.63)"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}